This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: Kin-Ya Kameda: Innovator in Diabetes Treatment
Introduction
Kin-Ya Kameda is a notable inventor based in Narashino, Japan. He has made significant contributions to the field of diabetes treatment through his innovative research and development of pharmaceutical compounds. His work has led to advancements that may improve the quality of life for individuals suffering from diabetes.
Latest Patents
Kin-Ya Kameda holds a patent for the treatment of diabetes using 2-substituted-1,3-diazacyclic compounds. This patent describes compounds of the formula wherein various substituents are defined, demonstrating distinct anti-diabetic activity in both humans and animals. The patent highlights the method for preparing these compounds and their salts, which are crucial for their therapeutic applications. He has 1 patent to his name.
Career Highlights
Kameda is associated with Daiichi Seiyaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. His work at the company has been instrumental in developing new treatments that address critical health issues, particularly diabetes.
Collaborations
Kin-Ya Kameda has collaborated with notable colleagues, including Akira Kosasayama and Yoshifumi Watanabe. Their combined expertise has contributed to the advancement of research in diabetes treatment.
Conclusion
Kin-Ya Kameda's contributions to diabetes treatment through his innovative patent reflect his dedication to improving healthcare. His work continues to inspire advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile